A rare but concerning fungal infection called Candida auris (C. auris) has been receiving increased attention in the United States because of its ability to resist several antifungal medications and spread easily in healthcare environments. Health authorities have described it as an emerging public health threat because it can cause serious infections, particularly among hospitalized patients and people with weakened immune systems.
Although news headlines may create concern, it is important to understand that Candida auris is not spreading through the general population like respiratory viruses such as influenza or COVID-19. For most healthy individuals living in the community, the risk remains very low. The greatest concern is for vulnerable patients in hospitals, intensive care units, and long-term care facilities.
What Is Candida auris?
Candida auris is a type of yeast, a group of fungi that can sometimes cause infections in humans. It was first identified in 2009 and has since been reported in many countries around the world. In the United States, cases have increased over recent years, making it one of the most important emerging fungal threats monitored by the Centers for Disease Control and Prevention (CDC).
Unlike many common fungal infections, Candida auris has several unusual characteristics. It can survive on surfaces for extended periods, spread between patients, and sometimes resist multiple antifungal medicines used for treatment.
This combination of easy transmission, difficulty in identification, and antifungal resistance makes Candida auris particularly challenging for healthcare systems.
Why Is Candida auris Concerning?
Most fungi do not cause serious illness in healthy people because the immune system can usually control them. However, Candida auris can become dangerous when it enters the bloodstream or deeper tissues.
In vulnerable patients, it can cause invasive infections such as bloodstream infections, which may lead to severe illness or sepsis. The infection can be difficult to treat because some strains do not respond well to commonly used antifungal medications.
A major concern among experts is not that everyone will become infected, but that hospitals and healthcare facilities may face challenges controlling outbreaks among high-risk patients.
Why Is It Called a Drug-Resistant Fungus?
Antifungal resistance occurs when fungi develop the ability to survive medicines designed to eliminate them. Candida auris is concerning because some strains are resistant to one or more classes of antifungal drugs.
Doctors commonly use a group of medicines called echinocandins as an initial treatment option for serious Candida auris infections. However, resistance can develop, and some infections may require specialized treatment guided by laboratory testing and infectious disease experts.
The rise of Candida auris reflects a broader global problem known as antimicrobial resistance, where microorganisms evolve and become harder to treat.
How Does Candida auris Spread?
Unlike fungal infections that people usually acquire from the environment, Candida auris spreads mainly through healthcare settings. It can spread through contact with:
- An infected or colonized patient
- Contaminated medical equipment
- Surfaces such as hospital beds, monitors, and other healthcare equipment
One of the reasons Candida auris can persist in hospitals is its ability to survive on surfaces longer than many other organisms. Strict cleaning procedures and infection-control measures are therefore essential to prevent transmission.
Who Is Most at Risk?
Healthy people usually have a very low chance of developing serious Candida auris infection. The infection mainly affects people who already have significant health problems or require prolonged medical care. People at higher risk include:
- Patients staying in hospitals for long periods
- Residents of nursing homes or long-term care facilities
- People with weakened immune systems
- Patients with central venous catheters or other medical devices
- Individuals who have received prolonged courses of antibiotics or antifungal medications
- Critically ill patients in intensive care units
Symptoms of Candida auris Infection
Symptoms depend on which part of the body is affected. Some people may carry Candida auris on their skin without feeling sick. This is called colonization, but colonized individuals can still spread the fungus to others. When infection occurs, symptoms may include:
- Fever and chills, especially with bloodstream infections
- Low blood pressure or signs of severe infection
- Pain, redness, or discharge from an infected wound
- Ear discomfort or drainage in ear infections
Because these symptoms are not specific, laboratory testing is required to confirm the diagnosis.
How Is Candida auris Diagnosed?
Diagnosing Candida auris can be challenging because it may be mistaken for other types of Candida fungi using routine laboratory methods.
Specialized testing is often needed to accurately identify the fungus and determine which antifungal medications are likely to work. Early recognition is extremely important because it allows healthcare teams to introduce infection-control measures and prevent further spread.
Treatment Options for Candida auris
Treatment depends on several factors, including the location of infection, the patient’s overall condition, and the resistance pattern of the fungus.
Doctors usually select antifungal medications based on laboratory sensitivity testing. In some cases, infections may require combinations of treatments or consultation with infectious disease specialists.
Because resistance can develop, preventing spread is just as important as treating individual infections.
How Can Candida auris Be Prevented?
Preventing Candida auris mainly depends on infection-control practices, especially in healthcare settings. Important strategies include:
- Regular hand hygiene among healthcare workers and visitors
- Proper cleaning and disinfection of medical equipment
- Identifying high-risk patients early
- Using appropriate isolation precautions when required
- Avoiding unnecessary use of antibiotics and antifungal medicines
For the general public, maintaining good hygiene and using antibiotics responsibly are important steps to reduce the broader problem of drug-resistant infections.
Should You Be Worried About Candida auris?
The increasing number of Candida auris cases is a serious reminder that drug-resistant infections are becoming more common worldwide. However, it is important not to misunderstand the risk.
Candida auris is primarily a healthcare-associated infection, not a fungus spreading easily among healthy people in everyday environments. The people who need the most protection are patients who are already medically vulnerable.
Awareness, early detection, and strong infection-control practices remain the best tools to control this emerging fungal threat.
Key Takeaway
Candida auris is a drug-resistant fungus that can cause serious infections, especially in hospitalized and immunocompromised patients. It spreads mainly in healthcare environments and can survive on surfaces, making infection control challenging. Although cases are increasing, the risk to healthy individuals remains low. Understanding the infection and preventing unnecessary antimicrobial use are important steps in fighting this growing public health challenge.
Sources
- Centers for Disease Control and Prevention (CDC) — Candida auris overview. https://www.cdc.gov/candida-auris/
- CDC — About Candida auris: Symptoms, spread, risk factors, and prevention. https://www.cdc.gov/candida-auris/about/index.html
- CDC — Tracking Candida auris cases in the United States. https://www.cdc.gov/candida-auris/tracking-c-auris/
- World Health Organization (WHO) — WHO fungal priority pathogens list. https://www.who.int/publications/i/item/9789240060241
- CDC — Antimicrobial Resistance Threats and Drug-Resistant Infections. https://www.cdc.gov/antimicrobial-resistance/
- European Centre for Disease Prevention and Control (ECDC) — Candida auris information and surveillance. https://www.ecdc.europa.eu/en/candida-auris
